A combination of heightened geopolitical friction and direct mandates from Washington has resulted in historically full order books for U.S. defense contractor Lockheed Martin. As the administration pushes for a massive ramp-up in weapons manufacturing, this political tailwind is elevating investor expectations. A central question remains: can the corporation translate these substantial capacity demands into profitable execution in the current environment?
Financial Performance and Political Mandates Converge
The foundation for the present bullish sentiment was laid by recent quarterly results. The defense giant secured long-term planning visibility by finishing its 2025 fiscal year with a record order backlog of $194 billion. This trajectory is being accelerated by explicit political pressure. During a meeting at the White House in early March, U.S. President Donald Trump urged major defense firms to significantly speed up, and ideally quadruple, production of advanced weapon systems. This directive is underpinned by a planned expansion of the U.S. defense budget to $1.5 trillion, from which Lockheed Martin, as a primary contractor, stands to gain substantially.
On the financial front, this demand is already making a marked impact. The company surpassed analyst estimates with fourth-quarter 2025 revenue of $20.32 billion. This performance was driven notably by robust 18 percent growth in its missiles and fire control segment.
Capacity Investments and Analyst Divergence
To manage the volume mandated by policymakers, Lockheed Martin is currently channeling $3.5 billion into expanding its production capabilities. These investments encompass new manufacturing facilities and overarching agreements to drastically increase output of THAAD interceptor missiles.
This fundamental strength is mirrored in the stock’s performance. Following an impressive rally, the shares trade at a current price of €569.60, sitting a mere 1.7 percent below the 52-week high reached in early March. However, some market observers advise caution, pointing to a recent contraction in the operating margin to 10.3 percent. Rising costs for materials and operations are pressuring rapid growth.
Consequently, analyst opinions are mixed. UBS raised its price target to $663, citing accelerated demand, while Goldman Sachs maintains a sell recommendation with a $517 target.
Outlook and Shareholder Returns
For the ongoing 2026 fiscal year, management anticipates revenue in the range of $77.5 to $80.0 billion, directly tied to the successful scaling of weapons production. In the near term, shareholders will participate in the company’s development through a declared quarterly dividend of $3.45 per share, scheduled for payout on March 27, 2026.